Panacea Life Sciences Holdings, Inc.
PLSH
Rank in Stocks
#32575
Panacea Life Sciences Holdings, Inc. operates as an integrated research and... Panacea Life Sciences Holdings, Inc. operates as an integrated research and production firm, specializing in cannabinoid and nutraceutical products across the entire supply chain, from sourcing to final sale. Its core mission is to develop and deliver natural, pharmaceutical-grade alternatives for both human and pet consumption. The company's diverse product range encompasses items such as softgels, edible gummies, liquid tinctures, sublingual tablets, and a variety of cosmetic and topical applications. In addition to these offerings, the company is involved in the personal protective equipment (PPE) market, importing and distributing hand sanitizers and masks. Panacea Life Sciences also provides white-label and contract manufacturing services to other cannabinoid companies, sells raw materials, and manages tolling arrangements. Established in 2008, the company is headquartered in Greenwood Village, Colorado.
Share Price
$0.06768
Last synced: 2026-11-06
Market Cap
$1.44M
Change (1 day)
2.55%
Change (1 year)
12.80%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Panacea Life Sciences Holdings, Inc. (PLSH)
Category
Healthcare
Operating Margin for Panacea Life Sciences Holdings, Inc. (PLSH)
Operating Margin as of November 2026 TTM: -289.21%
According to Panacea Life Sciences Holdings, Inc.'s latest financial reports, its current operating margin (TTM) is -289.21%. At the end of 2025 the company had an operating margin of -192.56%.
Operating Margin history for Panacea Life Sciences Holdings, Inc. from 2015 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -289.21% | 50.19% |
| 2025 | -192.56% | 207.06% |
| 2024 | -62.71% | -73.03% |
| 2023 | -232.55% | -29.91% |
| 2022 | -331.81% | 23.35% |
| 2021 | -269.00% | 361.33% |
| 2020 | -58.31% | -98.11% |
| 2019 | -3,087.46% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | -172,976.53% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.07% |
DE
|
|
| 19.68% | -100.07% |
DE
|
|
| 13.26% | -100.05% |
JP
|
|
| 17.08% | -100.06% |
CH
|
|
| 14.92% | -100.05% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Panacea Life Sciences Holdings, Inc.'s operating margin
What is Panacea Life Sciences Holdings, Inc.'s operating margin?
Panacea Life Sciences Holdings, Inc.'s operating margin is -289.21%, as of Nov 2026.
What was Panacea Life Sciences Holdings, Inc.'s operating margin in 2025?
In 2025, Panacea Life Sciences Holdings, Inc.'s operating margin was -192.56%, compared with -62.71% in 2024.
How has Panacea Life Sciences Holdings, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Panacea Life Sciences Holdings, Inc.'s operating margin was highest in 2020 (-58.31%) and lowest in 2022 (-331.81%).
How does Panacea Life Sciences Holdings, Inc.'s operating margin compare with similar companies?
Panacea Life Sciences Holdings, Inc.'s operating margin (-289.21%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.